Signaturefd, LLC G1 Therapeutics, Inc. Transaction History

Signaturefd, LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 31, 2024	SELL	$1.12 - $3.73 $48,806 - $162,542	-43,577 Reduced 97.95%	910 $2,000
Q1 2023 Apr 28, 2023	SELL	$2.57 - $8.16 $167 - $530	-65 Reduced 0.15%	44,487 $119,000
Q4 2022 Jan 27, 2023	SELL	$5.19 - $13.5 $544 - $1,417	-105 Reduced 0.24%	44,552 $241,000
Q3 2022 Nov 08, 2022	BUY	$5.17 - $16.99 $878 - $2,888	170 Added 0.38%	44,657 $558,000
Q2 2022 Aug 10, 2022	BUY	$4.04 - $8.51 $48,480 - $102,120	12,000 Added 36.94%	44,487 $220,000
Q2 2021 Jul 26, 2021	BUY	$19.57 - $26.32 $225,935 - $303,864	11,545 Added 55.13%	32,487 $713,000
Q4 2020 Feb 11, 2021	SELL	$10.99 - $20.4 $93,415 - $173,400	-8,500 Reduced 28.87%	20,942 $377,000
Q1 2020 Apr 23, 2020	BUY	$9.07 - $26.32 $77,095 - $223,720	8,500 Added 40.59%	29,442 $324,000
Q4 2019 Feb 05, 2020	SELL	$20.54 - $31.0 $349,180 - $527,000	-17,000 Reduced 44.81%	20,942 $553,000
Q4 2018 Feb 13, 2019	BUY	$16.51 - $51.33 $280,670 - $872,610	17,000 Added 81.18%	37,942 $727,000
Q3 2018 Nov 15, 2018	BUY	$43.15 - $67.97 $249,407 - $392,866	5,780 Added 38.12%	20,942 $1.1 Million
Q2 2018 Aug 14, 2018	BUY	$35.06 - $51.17 $531,579 - $775,839	15,162 New	15,162 $659,000

3.55M

11.7K

Ticker GTHX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,746,800
Market Cap $306M
Description
G1 Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of small molecule therapeutics for the treatment of patients with cancer. The company offers COSELA, which helps to decrease chemotherapy-induced myelosuppression in adult patients when administered prior to a platinum/...

Get notified when there are updates to the investment portfolio of Signaturefd, LLC, based on Form 13F filings with the SEC.

Stay updated on Signaturefd, LLC with notifications on news.